Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Consumer Healthcare Market to record USD 123.78 Bn growth; North America to have a significant market share -- Technavio


NEW YORK, Oct. 7, 2022 /PRNewswire/ -- The global consumer healthcare market size is expected to grow by USD 123.78 billion, accelerating at a CAGR of 5.66% between 2021 and 2026. According to the report, the market structure is fragmented due to the presence of several large and small vendors. The vendors in the market are adopting various strategies such as new product launches and strategic alliances to remain competitive and gain an edge over their rivals. Get detailed insights into the vendor landscape, successful strategies adopted by vendors, key product launches, and more by purchasing our full report. Download Sample PDF Report Before Purchasing

The report identifies Abbott Laboratories, Amway Corp., BASF SE, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Chr Hansen Holding AS, Danone SA, Eisai Co. Ltd., Genomma Lab Internacional SAB de CV, Glanbia Plc, GlaxoSmithKline Plc, Herbalife Nutrition Ltd., Himalaya Global Holdings Ltd., Johnson and Johnson, Kellogg Co., Koninklijke DSM NV, Merck KGaA, Nestle SA, NUTRITION ET SANTE, Pfizer Inc., Reckitt Benckiser Group PLC, and Sanofi as major market participants. Although increasing awareness about lifestyle diseases will offer immense growth opportunities, intense competition will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Consumer Healthcare Market 2022-2026: Segmentation

The global consumer healthcare market is segmented as below:

The market growth in the OTC pharmaceuticals segment will be significant over the forecast period. The segment is driven by the easy availability of OTC pharmaceuticals in pharmacies, hypermarkets, supermarkets, or other distribution channels. Also, the switch from prescription to OTC drugs and increased government reforms and support in the form of investments in the pharmaceutical sector are contributing to the growth of the segment.

33% of the market growth will come from North America during the forecast period. Factors such as the surge in the number of skin diseases, the rapid technological advances in the pharmaceutical sector, and the growth of the geriatric population are driving the growth of the regional market. Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our consumer healthcare market report covers the following areas:

Consumer Healthcare Market 2022-2026: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the consumer healthcare market, including some of the dominant vendors. Backed with competitive intelligence and benchmarking, our research report on the consumer healthcare market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Consumer Healthcare Market 2022-2026: Key Highlights

Related Reports:

Consumer Healthcare Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 5.66%

Market growth 2022-2026

USD 123.78 billion

Market structure

Fragmented

YoY growth (%)

5.13

Regional analysis

North America, Asia, Europe, and Rest of World (ROW)

Performing market contribution

North America at 33%

Key consumer countries

US, Canada, UK, Germany, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Amway Corp., BASF SE, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Chr Hansen Holding AS, Danone SA, Eisai Co. Ltd., Genomma Lab Internacional SAB de CV, Glanbia Plc, GlaxoSmithKline Plc, Herbalife Nutrition Ltd., Himalaya Global Holdings Ltd., Johnson and Johnson, Kellogg Co., Koninklijke DSM NV, Merck KGaA, Nestle SA, NUTRITION ET SANTE, Pfizer Inc., Reckitt Benckiser Group PLC, and Sanofi

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table Of Contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 02:30
Biophytis SA (Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a...

at 00:47
TRADING STATEMENT FOR THE SIX MONTHS ENDING 31 DECEMBER 2022 Sasol shareholders are advised that for the six months ending 31 December 2022 (2023 financial half year) earnings per share (EPS) and headline earnings per share (HEPS) are expected to...

at 00:01
ATTOM, a leading curator of real estate data nationwide for land and property data, today released a Special Housing Risk Report spotlighting county-level housing markets around the United States that are more or less vulnerable to declines, based on...

at 00:00
As a psychologist in rural West Virginia during the pandemic, Don Worth, Ph.D. was surprised that many of his patients got better during the stay-at-home orders, and yet when restrictions were lifted, they drifted back to old routines and their...

30 nov 2022
IVERIC bio, Inc. (the "Company"), today announced the pricing of an upsized underwritten public offering of 13,350,000 shares of its common stock at a price to the public of $22.50 per share, less underwriting discounts and commissions. In addition,...

30 nov 2022
Rubicon Organics Inc. ("Rubicon Organics" or the "Company"), a licensed producer focused on cultivating and selling organic certified and premium cannabis, is pleased to announce the publication of its second annual Environmental, Social and...



News published on 7 october 2022 at 18:45 and distributed by: